Correction: Efficacy and safety of ayurvedic intervention (Sarpgandha Mishran) vs. amlodipine for stage‑i primary hypertension‑ study protocol for a prospective double‑dummy, double‑blind, placebo‑controlled randomized clinical trial.
- DOI
- 10.1186/s12906-025-04921-y
- Published
- 2025 May 19
- Container
- BMC complementary medicine and therapies
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12906-025-04921-y,
title = {Correction: Efficacy and safety of ayurvedic intervention (Sarpgandha Mishran) vs. amlodipine for stage‑i primary hypertension‑ study protocol for a prospective double‑dummy, double‑blind, placebo‑controlled randomized clinical trial.},
author = {Yadav B and Rao B and Narang R and Jameela S and Khanduri S and Sharma S and Dinesh D and Srivastava A and Bhardwaj R and Gupta B and Srikanth N and Arya DS and Singhal R},
year = {2025},
journal = {BMC complementary medicine and therapies},
doi = {10.1186/s12906-025-04921-y},
url = {https://doi.org/10.1186/s12906-025-04921-y}
}RIS
TY - JOUR TI - Correction: Efficacy and safety of ayurvedic intervention (Sarpgandha Mishran) vs. amlodipine for stage‑i primary hypertension‑ study protocol for a prospective double‑dummy, double‑blind, placebo‑controlled randomized clinical trial. AU - Yadav B AU - Rao B AU - Narang R AU - Jameela S AU - Khanduri S AU - Sharma S AU - Dinesh D AU - Srivastava A AU - Bhardwaj R AU - Gupta B AU - Srikanth N AU - Arya DS AU - Singhal R PY - 2025 JO - BMC complementary medicine and therapies DO - 10.1186/s12906-025-04921-y UR - https://doi.org/10.1186/s12906-025-04921-y ER -
APA
B, Y., B, R., R, N., S, J., S, K., S, S., D, D., A, S., R, B., B, G., N, S., DS, A., & R, S. (2025). Correction: Efficacy and safety of ayurvedic intervention (Sarpgandha Mishran) vs. amlodipine for stage‑i primary hypertension‑ study protocol for a prospective double‑dummy, double‑blind, placebo‑controlled randomized clinical trial.. BMC complementary medicine and therapies. https://doi.org/10.1186/s12906-025-04921-y
Source records
- pubmed · retrieved 2026-09-26T01:30:29.194Z